Apimeds Pharmaceuticals US, Inc.
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
APUS | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 100 MATAWAN RD, 7747 MATAWAN
- Website:
- https://www.apimedsus.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Apimeds Pharmaceuticals US, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies to treat inflammation and pain. The company's lead program is Apitox, a novel, non-narcotic therapy derived from purified honey bee venom. Apitox is being clinically studied for treating pain and inflammation, particularly in patients with osteoarthritis. Apimeds operates on a principle it calls 'Actual Intelligence (ai²™),' which emphasizes human experience, scientific rigor, and clinical judgment to identify and develop overlooked or distressed clinical assets. This approach guides the company in navigating regulatory, intellectual property, and market access challenges, with a primary commitment to patients and physicians.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Apimeds Pharmaceuticals US, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Apimeds Pharmaceuticals US, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Apimeds Pharmaceuticals US, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
